Literature DB >> 29123595

Community pharmacist-led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer.

Satoshi Yokoyama1, Satoko Yajima1, Chihiro Sakai1, Shuji Yamashita1, Yoshihiro Noguchi1, Yoko Ino1, Kazuhiro Iguchi1, Hitomi Teramachi1.   

Abstract

Entities:  

Year:  2017        PMID： 29123595      PMCID： PMC5661674          DOI： 10.1177/1715163517732088

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  13 in total

1.  Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

Authors:  José Baselga; Mario Campone; Martine Piccart; Howard A Burris; Hope S Rugo; Tarek Sahmoud; Shinzaburo Noguchi; Michael Gnant; Kathleen I Pritchard; Fabienne Lebrun; J Thaddeus Beck; Yoshinori Ito; Denise Yardley; Ines Deleu; Alejandra Perez; Thomas Bachelot; Luc Vittori; Zhiying Xu; Pabak Mukhopadhyay; David Lebwohl; Gabriel N Hortobagyi
Journal:  N Engl J Med       Date:  2011-12-07       Impact factor: 91.245

2.  Effect of telephone follow-up on adherence to a diabetes therapeutic regimen.

Authors:  Maryam Nesari; Masoumeh Zakerimoghadam; Asadollah Rajab; Shiva Bassampour; Soghrat Faghihzadeh
Journal:  Jpn J Nurs Sci       Date:  2010-12       Impact factor: 1.418

3.  AntiC: A practice tool for the safe use of oral chemotherapeutics by community and hospital pharmacists.

Authors:  Tibor van Rooij; Serena Rix; Sharon Marsh
Journal:  Can Pharm J (Ott)       Date:  2015-05

4.  Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents.

Authors:  Michio Kimura; Makiko Go; Mina Iwai; Eiseki Usami; Hitomi Teramachi; Tomoaki Yoshimura
Journal:  J Oncol Pharm Pract       Date:  2016-06-20       Impact factor: 1.809

5.  Satisfaction with nurse-led telephone follow up for low to intermediate risk prostate cancer patients treated with radical radiotherapy. A comparative study.

Authors:  Mary Leahy; Meinir Krishnasamy; Alan Herschtal; Mathias Bressel; Tracey Dryden; Keen Hun Tai; Farshad Foroudi
Journal:  Eur J Oncol Nurs       Date:  2012-05-17       Impact factor: 2.398

6.  Follow-up telephone calls to patients discharged after undergoing orthopaedic surgery: double-blind, randomised controlled trial of efficacy.

Authors:  Marco Clari; Simona Frigerio; Fulvio Ricceri; Andrea Pici; Rosaria Alvaro; Valerio Dimonte
Journal:  J Clin Nurs       Date:  2015-02-23       Impact factor: 3.036

7.  Health state utilities for metastatic breast cancer.

Authors:  A Lloyd; B Nafees; J Narewska; S Dewilde; J Watkins
Journal:  Br J Cancer       Date:  2006-09-18       Impact factor: 7.640

Review 8.  Everolimus plus exemestane for the treatment of advanced breast cancer: a review of subanalyses from BOLERO-2.

Authors:  Gabriel N Hortobagyi
Journal:  Neoplasia       Date:  2015-03       Impact factor: 5.715

9.  Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2.

Authors:  Shinzaburo Noguchi; Norikazu Masuda; Hiroji Iwata; Hirofumi Mukai; Jun Horiguchi; Puttisak Puttawibul; Vichien Srimuninnimit; Yutaka Tokuda; Katsumasa Kuroi; Hirotaka Iwase; Hideo Inaji; Shozo Ohsumi; Woo-Chul Noh; Takahiro Nakayama; Shinji Ohno; Yoshiaki Rai; Byeong-Woo Park; Ashok Panneerselvam; Mona El-Hashimy; Tetiana Taran; Tarek Sahmoud; Yoshinori Ito
Journal:  Breast Cancer       Date:  2013-02-13       Impact factor: 4.239

Review 10.  Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice.

Authors:  Douglas E Peterson; Joyce A O'Shaughnessy; Hope S Rugo; Sharon Elad; Mark M Schubert; Chi T Viet; Cynthia Campbell-Baird; Jan Hronek; Virginia Seery; Josephine Divers; John Glaspy; Brian L Schmidt; Timothy F Meiller
Journal:  Cancer Med       Date:  2016-06-23       Impact factor: 4.452
View more
  1 in total

1.  Pharmacists' knowledge, attitudes, beliefs, and barriers toward breast cancer health promotion: a cross-sectional study in the Palestinian territories.

Authors:  Ramzi Shawahna; Hiba Awawdeh
Journal:  BMC Health Serv Res       Date:  2021-05-06       Impact factor: 2.655
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.